BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30667070)

  • 1. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria.
    Doña I; Jurado-Escobar R; Perkins JR; Ayuso P; Plaza-Serón MC; Pérez-Sánchez N; Campo P; Bogas-Herrera G; Bartra J; Torres MJ; Sanak M; Cornejo-García JA
    Allergy; 2019 Jun; 74(6):1135-1144. PubMed ID: 30667070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
    Kowalski ML; Woessner K; Sanak M
    J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in eicosanoid-related biosynthesis enzymes associated with acute urticaria/angioedema induced by nonsteroidal anti-inflammatory drug hypersensitivity.
    Jurado-Escobar R; Doña I; Perkins JR; Laguna JJ; Muñoz-Cano R; García-Sánchez A; Ayuso P; Torres MJ; Mayorga C; Cornejo-García JA
    Br J Dermatol; 2021 Oct; 185(4):815-824. PubMed ID: 33955560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study.
    Doña I; Blanca-López N; Torres MJ; Gómez F; Fernández J; Zambonino MA; Monteseirín FJ; Canto G; Blanca M; Cornejo-García JA
    Allergy; 2014 Apr; 69(4):438-44. PubMed ID: 24372026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients.
    Di Lorenzo G; Pacor ML; Vignola AM; Profita M; Esposito-Pellitteri M; Biasi D; Corrocher R; Caruso C
    Allergy; 2002 Dec; 57(12):1180-6. PubMed ID: 12464047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease.
    Cortellini G; Raiteri A; Galli M; Lotrionte M; Piscaglia F; Romano A
    J Thromb Thrombolysis; 2023 May; 55(4):762-769. PubMed ID: 36757645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil/Neutrophil/Platelet-to-Lymphocyte Ratios in Various Types of Immediate Hypersensitivity to NSAIDs: A Preliminary Study.
    Branicka O; Rogala B; Glück J
    Int Arch Allergy Immunol; 2020; 181(10):774-782. PubMed ID: 32814336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
    Doña I; Barrionuevo E; Salas M; Cornejo-García JA; Perkins JR; Bogas G; Prieto A; Torres MJ
    Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct transcriptomic and metabolomic profiles characterize NSAID-induced urticaria/angioedema patients undergoing aspirin desensitization.
    Tay SH; Santosa A; Goh ECH; Xu CX; Wu LH; Bigliardi-Qi M; Pakkiri LSS; Lee BTK; Drum CL; Bigliardi PL
    J Allergy Clin Immunol; 2022 Dec; 150(6):1486-1497. PubMed ID: 35964779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions.
    Saff RR; Banerji A
    Allergy Asthma Proc; 2015; 36(1):34-9. PubMed ID: 25562554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
    Nosbaum A; Braire-Bourrel M; Dubost R; Faudel A; Parat S; Nicolas JF; Bérard F
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):263-6. PubMed ID: 23535090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs.
    Doña I; Barrionuevo E; Salas M; Laguna JJ; Agúndez J; García-Martín E; Bogas G; Perkins JR; Cornejo-García JA; Torres MJ
    Sci Rep; 2018 Nov; 8(1):16710. PubMed ID: 30420763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.
    Chaudhry T; Hissaria P; Wiese M; Heddle R; Kette F; Smith WB
    Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of aspirin tolerance following omalizumab treatment in a patient with chronic spontaneous urticaria.
    Asero R
    Eur Ann Allergy Clin Immunol; 2018 Sep; 50(5):226-228. PubMed ID: 29384107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs.
    Dona I; Salas M; Perkins JR; Barrionuevo E; Gaeta F; Cornejo-Garcia JA; Campo P; Torres MJ
    Curr Pharm Des; 2016; 22(45):6784-6802. PubMed ID: 27779082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E
    Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
    Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-Adherent Leukocytes Associated With Cutaneous Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs.
    Jurado-Escobar R; Doña I; Bogas-Herrera G; Pérez-Sánchez N; Salas M; Laguna JJ; Muñoz-Cano R; Mayorga C; Torres MJ; Cornejo-García JA
    Front Pharmacol; 2020; 11():594427. PubMed ID: 33658935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma.
    Mastalerz L; Setkowicz M; Sanak M; Szczeklik A
    J Allergy Clin Immunol; 2004 Apr; 113(4):771-5. PubMed ID: 15100686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.